Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Revolution in Healthcare. A Transformative Investment Opportunity.

(Click image to play video) While the global COVID-19 pandemic has wreaked havoc on health and humanity over the past 12-month-plus, it has also invited a host of creative and innovative solutions to meet the needs of people who require a medical attention witho...

Should We Rethink Nuclear Power?

While it seems to fly in the face of everything we believe and have been taught about nuclear power, it may actually be the safest form of power production that we have. Ironically, the immense potency of the power of splitting an atom is simultaneously what makes nuclear weap...

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...

Bridging the Renewable Energy Infrastructure Gap

MGX Renewables Inc. Goes Public: “The sun doesn‘t shine all the time. The wind doesn‘t blow all the time. MGX Renewables mass storage batteries for the rest of the time.“ “A next-generation smart grid without energy storage is like a computer without a hard dri...

Recent Bonanza-Grade Gold Intercepts Mean These Companies Could Explode Higher Very Soon

Hitting bonanza grades during a gold bull means good things for investors. GoldStockBull subscribers know that gold mining stocks have done quite well in recent months. But companies that have recently found bonanza-grade gold have upside potential above and be...

Where Did Gold Come From: Black Holes, Aztecs And The Gods

Forever synonymous with wealth, gold has been the most coveted mineral on earth since its first recorded use back in 3000 BC. From Ancient Egypt to the U.S. Treasury its history is one of war, death, love and prosperity. But how did this most precious of precious metal...

Group Ten Delivers World-Class Drill Results for PGM

The world is at an interesting junction. Awash in debt caused by promises that governments cannot possibly fulfill, civil disorder takes place in at least fourteen different countries. The U.S. political system has tied itself into partisan knots in an effort to replay ...

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. In a Feb. 19 research note, analyst Yasmeen Rahimi reported that CymaBay Therapeutics Inc. (CBAY:NASDAQ) is having a strong Q1/19 with respect to cont...

'Strong Infill Drill Results' from Mining Company's Silver Project in Bolivia

The findings are presented and discussed in a BMO Capital Markets report. In an Aug. 27 research note, BMO Capital Markets analyst Ryan Thompson reported that "drill results continue to show the potential for New Pacific Metals Corp.'s (NUAG:TSX.V; NUPMF:OTCQX) Silv...

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...
1 2 3 4 5